Advertisement
Screener

ARTIVION, INC. (AORT) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

ARTIVION, INC. Research and Development Expense

ARTIVION, INC. (AORT) reported Research and Development Expense of $9.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07

  • ARTIVION, INC. research and development expense for the quarter ending 2026-06-30 was $9.05M, a 28.20% increase year-over-year.
  • ARTIVION, INC. research and development expense for the quarter ending 2026-03-31 was $8.84M, a 31.41% increase year-over-year.
  • ARTIVION, INC. research and development expense for the quarter ending 2025-12-31 was $9.12M, a 23.20% increase year-over-year.
  • ARTIVION, INC. research and development expense for the quarter ending 2025-09-30 was $8.08M, a 22.30% increase year-over-year.
  • ARTIVION, INC. research and development expense for fiscal 2025 was $30.99M, a 8.92% increase from fiscal 2024.
  • ARTIVION, INC. research and development expense for fiscal 2024 was $28.45M, a 0.89% decline from fiscal 2023.
  • ARTIVION, INC. research and development expense for fiscal 2023 was $28.71M, a 26.16% decline from fiscal 2022.
  • ARTIVION, INC. research and development expense for fiscal 2022 was $38.88M, a 9.38% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-06-30$9.05M
10-Q · filed 2026-08-07
$17.90M
10-Q · filed 2026-08-07
$27.02M
derived: sum of 3 quarters · filed 2026-08-07
$35.10M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$8.84M
10-Q · filed 2026-05-08
$17.96M
derived: sum of 2 quarters · filed 2026-05-08
$26.04M
derived: sum of 3 quarters · filed 2026-05-08
$33.10M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$9.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$17.20M
derived: sum of 2 quarters · filed 2026-02-18
$24.26M
derived: sum of 3 quarters · filed 2026-08-07
$30.99M
10-K · filed 2026-02-18
2025-09-30$8.08M
10-Q · filed 2025-11-07
$15.14M
derived: sum of 2 quarters · filed 2026-08-07
$21.87M
10-Q · filed 2025-11-07
$29.27M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$7.06M
10-Q · filed 2026-08-07
$13.79M
10-Q · filed 2026-08-07
$21.20M
derived: sum of 3 quarters · filed 2026-08-07
$27.80M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$6.73M
10-Q · filed 2026-05-08
$14.13M
derived: sum of 2 quarters · filed 2026-05-08
$20.74M
derived: sum of 3 quarters · filed 2026-05-08
$28.23M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$7.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$14.01M
derived: sum of 2 quarters · filed 2026-02-18
$21.51M
derived: sum of 3 quarters · filed 2026-02-18
$28.45M
10-K · filed 2026-02-18
2024-09-30$6.61M
10-Q · filed 2025-11-07
$14.10M
derived: sum of 2 quarters · filed 2025-11-07
$21.05M
10-Q · filed 2025-11-07
$28.69M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-30$7.50M
10-Q · filed 2025-08-08
$14.44M
10-Q · filed 2025-08-08
$22.09M
derived: sum of 3 quarters · filed 2026-02-18
$28.51M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-31$6.95M
10-Q · filed 2025-05-06
$14.59M
derived: sum of 2 quarters · filed 2026-02-18
$21.01M
derived: sum of 3 quarters · filed 2026-02-18
$28.43M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-31$7.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$14.07M
derived: sum of 2 quarters · filed 2026-02-18
$21.48M
derived: sum of 3 quarters · filed 2026-02-18
$28.71M
10-K · filed 2026-02-18
2023-09-30$6.42M
10-Q · filed 2024-11-08
$13.84M
derived: sum of 2 quarters · filed 2024-11-08
$21.06M
10-Q · filed 2024-11-08
$29.37M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$7.42M
10-Q · filed 2024-08-09
$14.64M
10-Q · filed 2024-08-09
$22.95M
derived: sum of 3 quarters · filed 2025-02-28
$34.74M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$7.22M
10-Q · filed 2024-05-07
$15.53M
derived: sum of 2 quarters · filed 2025-02-28
$27.33M
derived: sum of 3 quarters · filed 2025-02-28
$35.97M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$20.10M
derived: sum of 2 quarters · filed 2025-02-28
$28.75M
derived: sum of 3 quarters · filed 2025-02-28
$38.88M
10-K · filed 2025-02-28
2022-09-30$11.80M
10-Q · filed 2023-11-03
$20.45M
derived: sum of 2 quarters · filed 2023-11-03
$30.57M
10-Q · filed 2023-11-03
$40.03M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30$8.65M
10-Q · filed 2023-08-04
$18.78M
10-Q · filed 2023-08-04
$28.24M
derived: sum of 3 quarters · filed 2024-02-23
$38.21M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31$10.13M
10-Q · filed 2023-05-05
$19.59M
derived: sum of 2 quarters · filed 2024-02-23
$29.56M
derived: sum of 3 quarters · filed 2024-02-23
$37.92M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31$9.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$19.43M
derived: sum of 2 quarters · filed 2024-02-23
$27.79M
derived: sum of 3 quarters · filed 2024-02-23
$35.55M
10-K · filed 2024-02-23
2021-09-30$9.97M
10-Q · filed 2022-11-04
$18.33M
derived: sum of 2 quarters · filed 2022-11-04
$26.09M
10-Q · filed 2022-11-04
$32.66M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$8.36M
10-Q · filed 2022-08-05
$16.11M
10-Q · filed 2022-08-05
$22.69M
derived: sum of 3 quarters · filed 2023-02-23
$28.44M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$7.75M
10-Q · filed 2022-05-06
$14.33M
derived: sum of 2 quarters · filed 2023-02-23
$20.08M
derived: sum of 3 quarters · filed 2023-02-23
$25.61M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$6.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$12.33M
derived: sum of 2 quarters · filed 2023-02-23
$17.85M
derived: sum of 3 quarters · filed 2023-02-23
$24.21M
10-K · filed 2023-02-23
2020-09-30$5.75M
10-Q · filed 2021-11-05
$11.28M
derived: sum of 2 quarters · filed 2021-11-05
$17.63M
10-Q · filed 2021-11-05
$22.95M
derived: sum of 4 quarters · filed 2022-02-22
2020-06-30$5.52M
10-Q · filed 2021-07-30
$11.88M
10-Q · filed 2021-07-30
$17.19M
derived: sum of 3 quarters · filed 2022-02-22
$23.45M
derived: sum of 4 quarters · filed 2022-02-22
2020-03-31$6.36M
10-Q · filed 2021-04-30
$11.67M
derived: sum of 2 quarters · filed 2022-02-22
$17.93M
derived: sum of 3 quarters · filed 2022-02-22
$23.77M
derived: sum of 4 quarters · filed 2022-02-22
2019-12-31$5.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$11.57M
derived: sum of 2 quarters · filed 2022-02-22
$17.41M
derived: sum of 3 quarters · filed 2022-02-22
$22.96M
10-K · filed 2022-02-22
2019-09-30$6.26M
10-Q · filed 2020-11-05
$12.10M
derived: sum of 2 quarters · filed 2020-11-05
$17.65M
10-Q · filed 2020-11-05
$24.43M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30$5.84M
10-Q · filed 2020-07-31
$11.39M
10-Q · filed 2020-07-31
$18.17M
derived: sum of 3 quarters · filed 2021-02-23
$23.40M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$5.55M
10-Q · filed 2020-05-01
$12.33M
derived: sum of 2 quarters · filed 2021-02-23
$17.56M
derived: sum of 3 quarters · filed 2021-02-23
$23.28M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31$6.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$12.01M
derived: sum of 2 quarters · filed 2021-02-23
$17.73M
derived: sum of 3 quarters · filed 2021-02-23
$23.10M
10-K · filed 2021-02-23
2018-09-30$5.22M
10-Q · filed 2019-10-31
$10.94M
derived: sum of 2 quarters · filed 2019-10-31
$16.31M
10-Q · filed 2019-10-31
$22.68M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$5.72M
10-Q · filed 2019-07-31
$11.09M
10-Q · filed 2019-07-31
$17.45M
derived: sum of 3 quarters · filed 2020-02-19
$21.73M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$5.37M
10-Q · filed 2019-05-02
$11.73M
derived: sum of 2 quarters · filed 2020-02-19
$16.01M
derived: sum of 3 quarters · filed 2020-02-19
$20.74M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$6.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$10.64M
derived: sum of 2 quarters · filed 2020-02-19
$15.37M
derived: sum of 3 quarters · filed 2020-02-19
$19.46M
10-K · filed 2020-02-19
2017-09-30$4.28M
10-Q · filed 2018-11-01
$9.01M
derived: sum of 2 quarters · filed 2018-11-01
$13.10M
10-Q · filed 2018-11-01
$16.94M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$4.73M
10-Q · filed 2018-08-07
$8.82M
10-Q · filed 2018-08-07
$12.66M
derived: sum of 3 quarters · filed 2019-02-26
$16.38M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$4.09M
10-Q · filed 2018-05-04
$7.94M
derived: sum of 2 quarters · filed 2019-02-26
$11.65M
derived: sum of 3 quarters · filed 2019-02-26
$14.93M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$3.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$7.56M
derived: sum of 2 quarters · filed 2019-02-26
$10.84M
derived: sum of 3 quarters · filed 2019-02-26
$13.45M
10-K · filed 2019-02-26
2016-09-30$3.71M
10-Q · filed 2017-10-31
$6.99M
derived: sum of 2 quarters · filed 2017-10-31
$9.60M
10-Q · filed 2017-10-31
$12.14M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$3.28M
10-Q · filed 2017-07-25
$5.89M
10-Q · filed 2017-07-25
$8.43M
derived: sum of 3 quarters · filed 2018-03-09
$11.39M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31$2.61M
10-Q · filed 2017-04-27
$5.15M
derived: sum of 2 quarters · filed 2018-03-09
$8.11M
derived: sum of 3 quarters · filed 2018-03-09
$10.79M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31$2.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$5.50M
derived: sum of 2 quarters · filed 2018-03-09
$8.18M
derived: sum of 3 quarters · filed 2018-03-09
$10.44M
10-K · filed 2018-03-09
2015-09-30$2.96M
10-Q · filed 2016-10-27
$5.64M
derived: sum of 2 quarters · filed 2016-10-27
$7.90M
10-Q · filed 2016-10-27
$9.99M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30$2.68M
10-Q · filed 2016-07-26
$4.94M
10-Q · filed 2016-07-26
$7.03M
derived: sum of 3 quarters · filed 2017-02-16
$8.93M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-31$2.25M
10-Q · filed 2016-04-29
$4.34M
derived: sum of 2 quarters · filed 2017-02-16
$6.25M
derived: sum of 3 quarters · filed 2017-02-16
$8.45M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$2.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$3.99M
derived: sum of 2 quarters · filed 2017-02-16
$6.20M
derived: sum of 3 quarters · filed 2017-02-16
$8.70M
10-K · filed 2017-02-16
2014-09-30$1.90M
10-Q · filed 2015-10-27
$4.11M
derived: sum of 2 quarters · filed 2015-10-27
$6.61M
10-Q · filed 2015-10-27
$9.09M
derived: sum of 4 quarters · filed 2016-02-16
2014-06-30$2.20M
10-Q · filed 2015-07-28
$4.71M
10-Q · filed 2015-07-28
$7.18M
derived: sum of 3 quarters · filed 2016-02-16
$9.44M
derived: sum of 4 quarters · filed 2016-02-16
2014-03-31$2.50M
10-Q · filed 2015-04-29
$4.98M
derived: sum of 2 quarters · filed 2016-02-16
$7.23M
derived: sum of 3 quarters · filed 2016-02-16
$8.97M
derived: sum of 4 quarters · filed 2016-02-16
2013-12-31$2.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16
$4.73M
derived: sum of 2 quarters · filed 2016-02-16
$6.47M
derived: sum of 3 quarters · filed 2016-02-16
$8.45M
10-K · filed 2016-02-16
2013-09-30$2.25M
10-Q · filed 2014-10-28
$3.99M
derived: sum of 2 quarters · filed 2014-10-28
$5.98M
10-Q · filed 2014-10-28
$8.04M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-30$1.74M
10-Q · filed 2014-07-24
$3.72M
10-Q · filed 2014-07-24
$5.79M
derived: sum of 3 quarters · filed 2015-02-17
$7.62M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-31$1.99M
10-Q · filed 2014-04-30
$4.05M
derived: sum of 2 quarters · filed 2015-02-17
$5.88M
derived: sum of 3 quarters · filed 2015-02-17
$7.55M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-31$2.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
$3.89M
derived: sum of 2 quarters · filed 2015-02-17
$5.56M
derived: sum of 3 quarters · filed 2015-02-17
$7.26M
10-K · filed 2015-02-17
2012-09-30$1.83M
10-Q · filed 2013-10-29
$3.50M
derived: sum of 2 quarters · filed 2013-10-29
$5.19M
10-Q · filed 2013-10-29
$6.99M
derived: sum of 4 quarters · filed 2014-02-21
2012-06-30$1.67M
10-Q · filed 2013-07-25
$3.36M
10-Q · filed 2013-07-25
$5.16M
derived: sum of 3 quarters · filed 2014-02-21
$6.85M
derived: sum of 4 quarters · filed 2014-02-21
2012-03-31$1.69M
10-Q · filed 2013-04-30
$3.49M
derived: sum of 2 quarters · filed 2014-02-21
$5.18M
derived: sum of 3 quarters · filed 2014-02-21
$6.83M
derived: sum of 4 quarters · filed 2014-02-21
2011-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
$3.49M
derived: sum of 2 quarters · filed 2014-02-21
$5.13M
derived: sum of 3 quarters · filed 2014-02-21
$6.90M
10-K · filed 2014-02-21
2011-09-30$1.69M
10-Q · filed 2012-10-30
$3.33M
derived: sum of 2 quarters · filed 2012-10-30
$5.10M
10-Q · filed 2012-10-30
$6.90M
derived: sum of 4 quarters · filed 2013-02-15
2011-06-30$1.64M
10-Q · filed 2012-07-31
$3.41M
10-Q · filed 2012-07-31
$5.21M
derived: sum of 3 quarters · filed 2013-02-15
$6.80M
derived: sum of 4 quarters · filed 2013-02-15
2011-03-31$1.77M
10-Q · filed 2012-04-26
$3.57M
derived: sum of 2 quarters · filed 2013-02-15
$5.16M
derived: sum of 3 quarters · filed 2013-02-15
$6.40M
derived: sum of 4 quarters · filed 2013-02-15
2010-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$3.39M
derived: sum of 2 quarters · filed 2013-02-15
$4.63M
derived: sum of 3 quarters · filed 2013-02-15
$5.92M
10-K · filed 2013-02-15
2010-09-30$1.59M
10-Q · filed 2011-10-27
$2.83M
derived: sum of 2 quarters · filed 2011-10-27
$4.12M
10-Q · filed 2011-10-27
2010-06-30$1.24M
10-Q · filed 2011-07-29
$2.53M
10-Q · filed 2011-07-29
2009-12-31$5.25M
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92